Pfizer Inc.
PFE
$26.32
$0.381.47%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 279.00% | -59.44% | -112.08% | -101.06% | -93.25% |
| Total Depreciation and Amortization | 11.76% | 12.71% | 16.82% | 22.60% | 24.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.54% | -163.66% | 432.39% | 14,893.75% | 267.00% |
| Change in Net Operating Assets | -41.16% | 130.05% | 103.29% | 99.99% | 61.48% |
| Cash from Operations | 46.48% | -6.47% | -45.02% | -64.17% | -70.27% |
| Capital Expenditure | 25.54% | 21.43% | 17.97% | 6.97% | -20.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -158.41% | -158.41% | -158.94% | -88.85% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.07% | 889.51% | 757.31% | 74.60% | 44.11% |
| Cash from Investing | 108.22% | 73.84% | 86.12% | -159.77% | -104.51% |
| Total Debt Issued | -76.88% | -47.14% | -55.00% | 862.31% | 889.90% |
| Total Debt Repaid | -524.65% | -172.81% | -34.51% | -1.25% | 65.28% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.87% | -2.94% | -3.00% | -3.09% | -2.94% |
| Other Financing Activities | 25.79% | 22.08% | 10.80% | -114.76% | -88.66% |
| Cash from Financing | -165.76% | -142.18% | -142.03% | 316.80% | 275.72% |
| Foreign Exchange rate Adjustments | -65.00% | 41.54% | 24.76% | 60.24% | 75.76% |
| Miscellaneous Cash Flow Adjustments | -100.00% | -- | 250.00% | -- | -- |
| Net Change in Cash | -173.91% | -209.82% | -280.30% | -397.24% | 261.65% |
